View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
VA RIN: 2900-AN42 Publication ID: Spring 2011 
Title: Drug and Product Promotion by Pharmaceutical Company Representatives at VA Facilities  
Abstract: The Department of Veterans Affairs (VA) is amending a regulation intended to control the promotion of drugs at VA facilities and the business relationships between VHA staff and pharmaceutical sales representatives. The purposes of the amendment are to reduce or eliminate any potential for disruption in the patient care environment, manage activities and promotions at VA facilities, and provide sales representatives with a consistent standard of permissible business practice at VA facilities. It would also facilitate mutually beneficial relationships between VA and such sales representatives. 
Agency: Department of Veterans Affairs(VA)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 38 CFR 17   
Legal Authority: 38 USC 501(a)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  05/11/2010  75 FR 26160   
NPRM Comment Period End  07/12/2010    
Final Action  07/00/2011    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Louis E. Cobuzzi
Associate Chief Consultant (119)
Department of Veterans Affairs
810 Vermont Avenue NW,
Washington, DC 20420
Phone:202 461-7362
Email: louis.cobuzzi@va.gov